Gheuens Sarah
Chief Medical Officer
Exercise
Calculated transaction value
$196.73K
7,866 shares @ $25.01
Traded
Oct 26, 2026
Filed
Oct 28, 2026
We can't find the internet
Attempting to reconnectSomething went wrong!
Attempting to reconnect| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Gheuens Sarah Chief Medical Officer | Oct 28, 2026 2-day lag | Exercise Oct 26, 2026 | $196.73K Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Oct 28, 2026 2-day lag | Sale Oct 26, 2026 | $296.47K Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Oct 28, 2026 2-day lag | Exercise Oct 26, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Oct 23, 2026 1-day lag | Exercise Oct 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Oct 23, 2026 1-day lag | Exercise Oct 22, 2026 | $12.51K Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Oct 23, 2026 1-day lag | Sale Oct 22, 2026 | $18.76K Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Oct 23, 2026 2-day lag | Exercise Oct 21, 2026 | $37.24K Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Oct 23, 2026 2-day lag | Sale Oct 21, 2026 | $55.88K Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Oct 23, 2026 2-day lag | Exercise Oct 21, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Aug 6, 2026 2-day lag | Sale Aug 4, 2026 | $914.4K Filed shares x price | SEC Form 4 View filing | |
| Backstrom Jay T. Director | Jul 10, 2026 2-day lag | Award Jul 8, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Backstrom Jay T. Director | Jul 10, 2026 2-day lag | Exercise Jul 8, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Jul 2, 2026 1-day lag | Sale Jul 1, 2026 | $150.5K Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Jul 2, 2026 1-day lag | Exercise Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Chief Medical Officer | Jul 2, 2026 1-day lag | Exercise Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Goff Brian Chief Executive Officer | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Milanova Tsveta Chief Commercial Officer | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Owen Adams Catherine Director | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Foster-cheek Kaye I Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Capello Jeffrey D Director | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Smith Cynthia Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Fouse Jacqualyn A Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Smith Cynthia Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Backstrom Jay T. Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Scadden David Director | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Jones Cecilia Chief Financial Officer | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Goff Brian Chief Executive Officer | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ho Maykin Director | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ho Maykin Director | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Burns James William Chief Legal Officer | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing |